CLDN3 and neoplasm: Numerous studies demonstrated that in vitro and in vivo treatment with recombinant CPE exerted cytotoxic effects via pore formation (oncoleaking) on high Cldn3/4 expressing pancreatic, ovarian and breast cancer cells, which was associated with tumor reduction or elimination [26,27,28].